Related Experiment Video

Updated: Jun 25, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner

W M Rensen1, E Roscioli, A Tedeschi

  • 1IBPM Institute of Molecular Biology and Pathology, CNR National Research Council, Sapienza University of Rome, Rome, Italy.

Oncogene
|March 10, 2009
PubMed

Insights

RanBP1 protein downregulation triggers apoptosis in cancer cells, enhancing sensitivity to microtubule-targeting drugs like taxol. This suggests RanBP1 modulates cancer therapy outcomes.

Area of Science:

  • Cell Biology
  • Cancer Therapeutics
  • Molecular Oncology

Background:

  • Microtubule (MT)-targeting drugs are crucial in cancer treatment.
  • The GTPase Ran and its regulator RanBP1 are vital for mitotic spindle function.
  • RanBP1 is overexpressed in various cancer types, suggesting a role in tumorigenesis.

Purpose of the Study:

  • To investigate the role of RanBP1 in spontaneous and taxol-induced apoptosis in transformed cells.
  • To determine if RanBP1 influences the efficacy of microtubule-targeting cancer therapies.

Main Methods:

  • RNA interference (RNAi) was used to downregulate RanBP1 expression in transformed cell lines.
  • Apoptosis induction was assessed in RanBP1-depleted cells and control cells.
  • The response to taxol treatment was evaluated in cells with varying RanBP1 levels, including caspase-3 deficient cells.

Main Results:

  • RanBP1 downregulation induced apoptosis in multiple transformed cell lines, irrespective of p53 status.
  • Apoptosis was not observed in caspase-3 deficient cells, indicating a caspase-3 dependent mechanism.
  • RanBP1-interfered cells exhibited an enhanced apoptotic response to taxol, dependent on caspase-3 activity.

Conclusions:

  • RanBP1 plays a significant role in regulating apoptosis during mitosis.
  • RanBP1 levels can modulate the cellular response to microtubule-targeting agents like taxol.
  • Targeting RanBP1 may represent a strategy to enhance the effectiveness of current cancer chemotherapies.

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...